Business
United States resumes Johnson & Johnson vaccine rollout following 10-day pause over blood clot concerns – ABC News
The United States can resume use of Johnson & Johnson’s COVID-19 vaccine immediately, top health regulators say, ending a 10-day pause to investigate the vaccine’s…
The United States can resume use of Johnson & Johnson’s COVID-19 vaccine immediately, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine’s link to extremely rare but potentially deadly blood clots.
Key points:
- The CDC panel voted 10-4 that the Johnson & Johnson COVID-19 vaccine be recommended for use in people 18 years of age and older
- Johnson & Johnson’s chief scientific officer Paul Stoffels said the committee’s recommendation was “an essential step toward continuing…
-
General19 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General23 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
General6 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General10 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals